Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drug Retailers
- Sub-Industry: Health Care Distributors
- Symbol: NYSE:CAH
- CUSIP: 14149Y10
- Web: www.cardinalhealth.com
Capitalization:- Market Cap: $21.01229 billion
- Outstanding Shares: 316,453,000
Average Prices:- 50 Day Moving Avg: $67.69
- 200 Day Moving Avg: $74.72
- 52 Week Range: $62.70 - $84.88
P/E:- Trailing P/E Ratio: 16.54
- Foreward P/E Ratio: 12.08
- P/E Growth: 2.43
Sales & Book Value:- Annual Revenue: $129.98 billion
- Price / Sales: 0.16
- Book Value: $21.54 per share
- Price / Book: 3.09
Dividend:- Annual Dividend: $1.85
- Dividend Yield: 2.8%
Profitability:- EBIDTA: $3.07 billion
- Net Margins: 0.99%
- Return on Equity: 26.20%
- Return on Assets: 4.81%
Debt:- Debt-to-Equity Ratio: 1.33%
- Current Ratio: 1.34%
- Quick Ratio: 0.80%
Misc:- Average Volume: 2.13 million shs.
- Beta: 0.85
- Short Ratio: 4.82
Frequently Asked Questions for Cardinal Health (NYSE:CAH)
What is Cardinal Health's stock symbol?
Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."
How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?
Cardinal Health announced a quarterly dividend on Wednesday, August 9th. Investors of record on Monday, October 2nd will be paid a dividend of $0.4624 per share on Sunday, October 15th. This represents a $1.85 dividend on an annualized basis and a yield of 2.77%. The ex-dividend date of this dividend is Friday, September 29th. View Cardinal Health's Dividend History.
How were Cardinal Health's earnings last quarter?
Cardinal Health, Inc. (NYSE:CAH) issued its quarterly earnings results on Wednesday, August, 2nd. The company reported $1.31 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.24 by $0.07. The firm earned $32.97 billion during the quarter, compared to the consensus estimate of $32.73 billion. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The business's revenue was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.14 EPS. View Cardinal Health's Earnings History.
When will Cardinal Health make its next earnings announcement?
What guidance has Cardinal Health issued on next quarter's earnings?
Cardinal Health issued an update on its FY18 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share (EPS) guidance of $5.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.25. Cardinal Health also updated its FY17 guidance to $4.85-5.10 EPS.
Where is Cardinal Health's stock going? Where will Cardinal Health's stock price be in 2017?
13 analysts have issued 12 month target prices for Cardinal Health's shares. Their predictions range from $72.00 to $82.00. On average, they anticipate Cardinal Health's stock price to reach $76.78 in the next year. View Analyst Ratings for Cardinal Health.
Who are some of Cardinal Health's key competitors?
Some companies that are related to Cardinal Health include Boston Scientific Corporation (BSX), Intuitive Surgical (ISRG), Vertex Pharmaceuticals Incorporated (VRTX), Express Scripts Holding Company (ESRX), Baxter International (BAX), Humana (HUM), McKesson Corporation (MCK), Alexion Pharmaceuticals (ALXN), Zoetis (ZTS), Fresenius Medical Care Corporation (FMS), Illumina (ILMN), Actelion (ALIOF), HCA Holdings (HCA), Edwards Lifesciences Corporation (EW), Incyte Corporation (INCY), C.R. Bard (BCR), Zimmer Biomet Holdings (ZBH) and Cerner Corporation (CERN).
Who are Cardinal Health's key executives?
Cardinal Health's management team includes the folowing people:
- George S. Barrett, Chairman of the Board, Chief Executive Officer
- Michael C. Kaufmann, Chief Financial Officer
- Donald M. Casey Jr., Chief Executive Officer - Medical Segment
- Jon L. Giacomin, Chief Executive Officer - Pharmaceutical segment
- Pamela O. Kimmet, Chief Human Resource Officer
- Patricia B. Morrison, Executive Vice President - Customer Support Services and Chief Information Officer
- Craig S. Morford, Chief Legal and Compliance Officer
- Gregory B. Kenny, Lead Independent Director
- David John Anderson, Independent Director
- Colleen F. Arnold, Independent Director
Who owns Cardinal Health stock?
Cardinal Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.48%), BlackRock Inc. (7.23%), State Street Corp (5.25%), Macquarie Group Ltd. (3.06%), Franklin Resources Inc. (1.99%) and Northern Trust Corp (1.38%). Company insiders that own Cardinal Health stock include Carole S Watkins, Craig S Morford, Donald M Jr Casey, Falk T Stephen, George S Barrett, Jon L Giacomin, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.
Who sold Cardinal Health stock? Who is selling Cardinal Health stock?
Cardinal Health's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Janus Henderson Group PLC, American Century Companies Inc., Schroder Investment Management Group, Wells Fargo & Company MN, LSV Asset Management, Bank of New York Mellon Corp and US Bancorp DE. Company insiders that have sold Cardinal Health stock in the last year include George S Barrett and Jon L Giacomin. View Insider Buying and Selling for Cardinal Health.
Who bought Cardinal Health stock? Who is buying Cardinal Health stock?
Cardinal Health's stock was purchased by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Ameriprise Financial Inc., BlackRock Inc., HealthCor Management L.P., Teachers Advisors LLC, Balyasny Asset Management LLC, Artisan Partners Limited Partnership and Vanguard Group Inc.. View Insider Buying and Selling for Cardinal Health.
How do I buy Cardinal Health stock?
Shares of Cardinal Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cardinal Health's stock price today?
One share of Cardinal Health stock can currently be purchased for approximately $66.66.
MarketBeat Community Rating for Cardinal Health (NYSE CAH)MarketBeat's community ratings are surveys of what our community members think about Cardinal Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Cardinal Health (NYSE:CAH) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 10 Hold Ratings, 3 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.23) |
| Consensus Price Target: | $76.78 (15.18% upside) |
Analysts' Ratings History for Cardinal Health (NYSE:CAH)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/19/2017 | Royal Bank Of Canada | Initiated Coverage | Sector Perform -> Sector Perform | $72.00 | Low |  |
| 9/17/2017 | Robert W. Baird | Reiterated Rating | Hold | $73.00 | Low | |
| 9/10/2017 | Needham & Company LLC | Reiterated Rating | Hold | | Low | |
| 8/29/2017 | Jefferies Group LLC | Set Price Target | Hold | $77.00 | Low | |
| 8/3/2017 | Cowen and Company | Reiterated Rating | Market Perform | $82.00 -> $77.00 | Low | |
| 8/3/2017 | Credit Suisse Group | Lower Price Target | Outperform | $87.00 -> $81.00 | Medium | |
| 7/4/2017 | Evercore ISI | Reiterated Rating | Outperform | | N/A | |
| 4/28/2017 | Tigress Financial | Initiated Coverage | Neutral -> Neutral | | Low | |
| 4/22/2017 | Barclays PLC | Reiterated Rating | Overweight | $88.00 -> $82.00 | Low | |
| 4/21/2017 | Leerink Swann | Set Price Target | Hold | $72.00 | Low | |
| 4/19/2017 | William Blair | Downgrade | Outperform -> Market Perform | | Low | |
| 1/3/2017 | Mizuho | Downgrade | Buy -> Neutral | $79.00 | N/A | |
| 10/10/2016 | Cleveland Research | Downgrade | Buy -> Neutral | | N/A | |
| 9/19/2016 | Bank of America Corporation | Reiterated Rating | Hold | $90.00 | N/A | |
| 9/16/2016 | Goldman Sachs Group, Inc. (The) | Downgrade | Buy -> Neutral | $90.00 -> $83.00 | N/A | |
| 9/12/2016 | Morgan Stanley | Reiterated Rating | Hold | $91.00 | N/A | |
| 8/4/2016 | Deutsche Bank AG | Boost Price Target | Hold | $83.00 -> $89.00 | N/A | |
| 8/3/2016 | Citigroup Inc. | Boost Price Target | Neutral | $87.00 -> $93.00 | N/A | |
| 6/20/2016 | FBR & Co | Reiterated Rating | Buy | | N/A | |
| 6/1/2016 | Raymond James Financial, Inc. | Downgrade | Outperform -> Market Perform | | N/A | |
| 4/18/2016 | Avondale Partners | Initiated Coverage | Outperform | $111.00 | N/A | |
(Data available from 9/25/2015 forward)
Earnings History for Cardinal Health (NYSE:CAH)Earnings History by Quarter for Cardinal Health (NYSE CAH)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/30/2017 | | $1.12 | | | | | N/A | |
| 8/2/2017 | Q4 2017 | $1.24 | $1.31 | $32.73 billion | $32.97 billion | View | Listen | |
| 5/1/2017 | Q3 2017 | $1.46 | $1.53 | $32.30 billion | $31.82 billion | View | Listen | |
| 2/7/2017 | Q217 | $1.23 | $1.34 | $33.63 billion | $33.10 billion | View | Listen | |
| 10/31/2016 | Q117 | $1.21 | $1.24 | $31.12 billion | $32.00 billion | View | Listen | |
| 8/2/2016 | Q416 | $1.13 | $1.14 | $31.06 billion | $31.40 billion | View | N/A | |
| 4/28/2016 | Q316 | $1.33 | $1.43 | $30.54 billion | $30.70 billion | View | Listen | |
| 2/1/2016 | Q216 | $1.26 | $1.30 | $29.23 billion | $31.40 billion | View | N/A | |
| 11/2/2015 | Q116 | $1.10 | $1.38 | $27.19 billion | $28.10 billion | View | N/A | |
| 7/30/2015 | Q415 | $0.99 | $1.00 | $26.05 billion | $27.50 billion | View | Listen | |
| 4/30/2015 | Q3 | $1.16 | $1.19 | $24.40 billion | $25.38 billion | View | N/A | |
| 1/29/2015 | Q215 | $1.11 | $1.20 | $23.43 billion | $25.50 billion | View | N/A | |
| 10/30/2014 | Q115 | $0.96 | $1.00 | $22.43 billion | $24.07 billion | View | N/A | |
| 8/4/2014 | Q414 | $0.81 | $0.83 | $21.88 billion | $2.90 billion | View | N/A | |
| 5/1/2014 | Q314 | $1.01 | $1.01 | $21.72 million | $21.40 million | View | N/A | |
| 1/31/2014 | Q214 | $0.84 | $0.79 | $20.74 billion | $22.20 billion | View | N/A | |
| 10/31/2013 | Q114 | $0.86 | $1.10 | $22.73 billion | $24.50 billion | View | N/A | |
| 8/1/2013 | Q4 2013 | $0.77 | $0.79 | $24.56 billion | $25.40 billion | View | N/A | |
| 5/2/2013 | Q3 2013 | $0.95 | $1.20 | $24.72 billion | $24.60 billion | View | N/A | |
| 2/5/2013 | Q2 2013 | $0.86 | $0.93 | $24.61 million | $22.75 million | View | N/A | |
| 10/30/2012 | Q113 | $0.79 | $0.81 | $26.33 million | $25.90 million | View | N/A | |
| 8/2/2012 | | $0.73 | $0.73 | | | View | N/A | |
| 5/3/2012 | | $0.88 | $0.94 | | | View | N/A | |
| 2/2/2012 | | $0.77 | $0.81 | | | View | N/A | |
| 10/27/2011 | | $0.72 | $0.73 | | | View | N/A | |
| 8/4/2011 | | $0.58 | $0.59 | | | View | N/A | |
| 4/28/2011 | | $0.69 | $0.75 | | | View | N/A | |
| 2/3/2011 | | $0.61 | $0.69 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Cardinal Health (NYSE:CAH)2017 EPS Consensus Estimate: $5.28
2018 EPS Consensus Estimate: $5.03
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 3 | $1.21 | $1.26 | $1.23 |
| Q2 2017 | 3 | $1.20 | $1.33 | $1.26 |
| Q3 2017 | 3 | $1.43 | $1.60 | $1.50 |
| Q4 2017 | 4 | $1.24 | $1.41 | $1.29 |
| Q1 2018 | 3 | $0.99 | $1.18 | $1.08 |
| Q2 2018 | 3 | $1.13 | $1.34 | $1.23 |
| Q3 2018 | 3 | $1.41 | $1.55 | $1.46 |
| Q4 2018 | 3 | $1.20 | $1.30 | $1.27 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Cardinal Health (NYSE:CAH)| Next Dividend: | 10/15/2017 |
| Annual Dividend: | $1.85 |
| Dividend Yield: | 2.78% |
| Dividend Growth: | 13.10% (3 Year Average) |
| Payout Ratio: | 45.79% (Trailing 12 Months of Earnings)
37.37% (Based on This Year's Estimates)
33.51% (Based on Next Year's Estimates)
|
| Track Record: | 12 Years of Consecutive Dividend Growth |
Dividend History by Quarter for Cardinal Health (NYSE CAH)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 8/9/2017 | quarterly | $0.46 | 2.75% | 9/29/2017 | 10/2/2017 | 10/15/2017 |
| 5/3/2017 | quarterly | $0.46 | 2.54% | 6/29/2017 | 7/3/2017 | 7/15/2017 |
| 2/2/2017 | quarterly | $0.45 | 2.4% | 3/30/2017 | 4/3/2017 | 4/15/2017 |
| 11/3/2016 | quarterly | $0.45 | 2.76% | 12/29/2016 | 1/3/2017 | 1/15/2017 |
| 8/8/2016 | quarterly | $0.45 | 2.14% | 9/29/2016 | 10/3/2016 | 10/15/2016 |
| 5/4/2016 | quarterly | $0.45 | 2.29% | 6/29/2016 | 7/1/2016 | 7/15/2016 |
| 2/2/2016 | quarterly | $0.39 | 2% | 3/30/2016 | 4/1/2016 | 4/15/2016 |
| 11/4/2015 | quarterly | $0.39 | 1.76% | 12/30/2015 | 1/4/2016 | 1/15/2016 |
| 8/5/2015 | quarterly | $0.39 | 1.83% | 9/29/2015 | 10/1/2015 | 10/15/2015 |
| 5/6/2015 | quarterly | $0.39 | 1.82% | 6/29/2015 | 7/1/2015 | 7/15/2015 |
| 2/3/2015 | quarterly | $0.34 | 1.62% | 3/30/2015 | 4/1/2015 | 4/15/2015 |
| 11/5/2014 | quarterly | $0.34 | 1.72% | 12/30/2014 | 1/2/2015 | 1/15/2015 |
| 8/6/2014 | quarterly | $0.34 | 1.96% | 9/29/2014 | 10/1/2014 | 10/15/2014 |
| 5/7/2014 | quarterly | $0.34 | 2.14% | 6/27/2014 | 7/1/2014 | 7/15/2014 |
| 2/5/2014 | quarterly | $0.30 | 1.83% | 3/28/2014 | 4/1/2014 | 4/15/2014 |
| 11/6/2013 | quarterly | $0.30 | 1.99% | 12/30/2013 | 1/2/2014 | 1/15/2014 |
| 8/7/2013 | quarterly | $0.30 | 2.35% | 9/27/2013 | 10/1/2013 | 10/15/2013 |
| 5/2/2013 | quarterly | $0.30 | 2.61% | 6/27/2013 | 7/1/2013 | 7/15/2013 |
| 2/6/2013 | quarterly | $0.28 | 2.46% | 3/27/2013 | 4/1/2013 | 4/15/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Cardinal Health (NYSE:CAH)Insider Ownership Percentage: 0.97%
Institutional Ownership Percentage: 87.63%
Insider Trades by Quarter for Cardinal Health (NYSE:CAH)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/12/2017 | Jon L Giacomin | CEO of Cardinal Health's pharmaceutical segment | Sell | 23,270 | $72.87 | $1,695,684.90 | |
| 2/10/2017 | George S Barrett | Chairman | Sell | 217,994 | $77.23 | $16,835,676.62 | |
| 11/10/2016 | George S Barrett | Chairman | Sell | 217,995 | $71.29 | $15,540,863.55 | |
| 8/18/2016 | Patricia Morrison | Insider | Sell | 43,959 | $82.50 | $3,626,617.50 | |
| 8/18/2016 | Stuart G Laws | SVP | Sell | 9,703 | $82.45 | $800,012.35 | |
| 8/16/2016 | Jon L Giacomin | CEO | Sell | 47,251 | $82.77 | $3,910,965.27 | |
| 8/11/2016 | Craig S Morford | Insider | Sell | 12,697 | $83.13 | $1,055,501.61 | |
| 8/10/2016 | Donald M Jr. Casey | CEO | Sell | 59,180 | $83.59 | $4,946,856.20 | |
| 8/10/2016 | George S Barrett | Chairman | Sell | 250,000 | $83.63 | $20,907,500.00 | |
| 8/9/2016 | George S Barrett | CEO | Sell | 129,818 | $83.76 | $10,873,555.68 | |
| 8/8/2016 | George S Barrett | CEO | Sell | 20,428 | $83.75 | $1,710,845.00 | |
| 5/20/2016 | Carole S Watkins | Insider | Sell | 84,617 | $77.33 | $6,543,432.61 | |
| 11/6/2015 | Falk T. Stephen | EVP | Sell | 30,085 | $87.66 | $2,637,251.10 | |
| 8/20/2015 | George S. Barrett | CEO | Sell | 300,000 | $83.08 | $24,924,000.00 | |
| 5/12/2015 | Falk T Stephen | EVP | Sell | 39,428 | $86.12 | $3,395,539.36 | |
| 5/11/2015 | George S Barrett | CEO | Sell | 300,000 | $86.44 | $25,932,000.00 | |
| 3/4/2015 | Colleen F Arnold | Director | Sell | 9,801 | $87.65 | $859,057.65 | |
| 3/3/2015 | Richard C Notebaert | Director | Sell | 9,801 | $88.20 | $864,448.20 | |
| 2/20/2015 | Carole S Watkins | Insider | Sell | 33,847 | $87.00 | $2,944,689.00 | |
| 2/10/2015 | Carole S Watkins | Insider | Sell | 50,770 | $85.00 | $4,315,450.00 | |
| 2/10/2015 | George S Barrett | CEO | Sell | 300,000 | $84.87 | $25,461,000.00 | |
| 11/7/2014 | Mark R Blake | EVP | Sell | 24,668 | $79.50 | $1,961,106.00 | |
| 9/5/2014 | Carole S Watkins | Insider | Sell | 40,794 | $75.00 | $3,059,550.00 | |
| 9/4/2014 | Michael C Kaufmann | CEO | Sell | 50,216 | $74.95 | $3,763,689.20 | |
| 8/27/2014 | Jeffrey William Henderson | CFO | Sell | 26,567 | $72.63 | $1,929,561.21 | |
| 8/18/2014 | Jeffrey William Henderson | CFO | Sell | 78,637 | $72.06 | $5,666,582.22 | |
| 8/18/2014 | Mark R Blake | EVP | Sell | 4,782 | $72.15 | $345,021.30 | |
| 8/18/2014 | Michael C Kaufmann | CEO | Sell | 6,833 | $72.06 | $492,385.98 | |
| 8/8/2014 | Craig S Morford | Insider | Sell | 43,359 | $70.03 | $3,036,430.77 | |
| 8/8/2014 | Jeffrey William Henderson | CFO | Sell | 118,093 | $69.72 | $8,233,443.96 | |
| 7/24/2014 | Mark R Blake | EVP | Sell | 23,114 | $73.41 | $1,696,798.74 | |
| 7/24/2014 | Stuart G Laws | CAO | Sell | 21,266 | $72.50 | $1,541,785.00 | |
| 7/14/2014 | Jeffrey William Henderson | CFO | Sell | 23,632 | $70.65 | $1,669,600.80 | |
| 5/19/2014 | Mark Blake | EVP | Sell | 4,703 | $66.50 | $312,749.50 | |
| 5/13/2014 | Mark Blake | EVP | Sell | 2,822 | $66.50 | $187,663.00 | |
| 5/7/2014 | Jeffrey William Henderson | CFO | Sell | 27,031 | $63.83 | $1,725,388.73 | |
| 2/11/2014 | Mark Blake | EVP | Sell | 2,330 | $68.53 | $159,674.90 | |
| 2/11/2014 | Michael Kaufmann | CEO | Sell | 388,995 | $67.46 | $26,241,602.70 | |
| 2/10/2014 | George Barrett | CEO | Sell | 200,000 | $66.64 | $13,328,000.00 | |
| 2/5/2014 | Gregory Kenny | Director | Sell | 18,175 | $65.39 | $1,188,463.25 | |
| 2/4/2014 | Carole Watkins | Insider | Sell | 46,666 | $65.71 | $3,066,422.86 | |
| 2/4/2014 | Falk Stephen | EVP | Sell | 17,926 | $65.56 | $1,175,228.56 | |
| 2/4/2014 | Richard Notebaert | Director | Sell | 10,727 | $65.68 | $704,549.36 | |
| 11/11/2013 | George Barrett | CEO | Sell | 200,000 | $62.71 | $12,542,000.00 | |
| 9/11/2013 | Mark R Blake | EVP | Sell | 14,584 | $51.53 | $751,513.52 | |
| 8/19/2013 | Mark Blake | EVP | Sell | 4,925 | $51.27 | $252,504.75 | |
| 8/16/2013 | Falk Stephen | EVP | Sell | 10,000 | $51.50 | $515,000.00 | |
| 8/15/2013 | Craig Morford | Insider | Sell | 20,000 | $51.33 | $1,026,600.00 | |
| 8/13/2013 | George Barrett | CEO | Sell | 75,000 | $52.09 | $3,906,750.00 | |
| 8/13/2013 | Jeffrey William Henderson | CFO | Sell | 54,590 | $51.99 | $2,838,134.10 | |
| 8/8/2013 | Calvin Darden | Director | Sell | 3,254 | $51.48 | $167,515.92 | |
| 8/5/2013 | Mark Blake | EVP | Sell | 29,166 | $51.53 | $1,502,923.98 | |
| 7/26/2013 | Jeffrey William Henderson | CFO | Sell | 76,781 | $50.99 | $3,915,063.19 | |
| 7/18/2013 | Jeffrey William Henderson | CFO | Sell | 57,623 | $49.99 | $2,880,573.77 | |
| 7/15/2013 | Jeffrey William Henderson | CFO | Sell | 14,660 | $49.99 | $732,853.40 | |
| 7/11/2013 | Jeffrey William Henderson | CFO | Sell | 83,211 | $48.99 | $4,076,506.89 | |
| 6/19/2013 | John F Finn | Director | Sell | 11,070 | $48.51 | $537,005.70 | |
| 5/28/2013 | Jean G Spaulding | Director | Sell | 8,350 | $47.35 | $395,372.50 | |
| 5/22/2013 | Richard C Notebaert | Director | Sell | 3,197 | $48.10 | $153,775.70 | |
| 5/20/2013 | Carole S Watkins | Insider | Sell | 4,612 | $48.00 | $221,376.00 | |
| 5/20/2013 | Jean G Spaulding | Director | Sell | 1,666 | $47.90 | $79,801.40 | |
| 11/1/2012 | Stuart G Laws | CAO | Sell | 2,564 | $41.22 | $105,688.08 | |
| 10/4/2012 | Jeffrey William Henderson | CFO | Sell | 46,226 | $40.00 | $1,849,040.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Cardinal Health (NYSE:CAH)
Latest Headlines for Cardinal Health (NYSE:CAH)
| Source: |
|
| Date | Headline |
|---|
 | Cardinal Health: A Dividend Aristocrat Trading Near Its All-Time High Yield - Seeking Alpha
seekingalpha.com - September 20 at 10:42 PM |
 | Cardinal Health, Inc. (CAH) Research Coverage Started at Royal Bank Of Canada
www.americanbankingnews.com - September 19 at 7:38 AM |
| Cardinal Health, Inc. (CAH) Stock Rating Reaffirmed by Robert W. Baird
www.americanbankingnews.com - September 17 at 7:42 AM |
 | How Safe Is Cardinal Health's Dividend?
finance.yahoo.com - September 15 at 5:18 PM |
 | How Safe Is Cardinal Health's Dividend?
www.fool.com - September 15 at 8:16 AM |
| Analysts Anticipate Cardinal Health, Inc. (CAH) Will Announce Quarterly Sales of $33.44 Billion
www.americanbankingnews.com - September 15 at 3:18 AM |
| Analysts Anticipate Cardinal Health, Inc. (CAH) Will Announce Earnings of $1.01 Per Share
www.americanbankingnews.com - September 14 at 12:24 AM |
| Cardinal Health (CAH) and Prestige Brand Holdings (PBH) Critical Analysis
www.americanbankingnews.com - September 11 at 10:32 PM |
| Needham & Company LLC Reaffirms Hold Rating for Cardinal Health, Inc. (CAH)
www.americanbankingnews.com - September 11 at 8:24 PM |
| Cardinal Health, Inc. (CAH) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 9 at 4:48 PM |
 | Why Is Cardinal Health (CAH) Down 2.7% Since the Last Earnings Report? - Nasdaq
www.nasdaq.com - September 9 at 3:21 AM |
| Why Is Cardinal Health (CAH) Down 2.7% Since the Last Earnings Report?
finance.yahoo.com - September 8 at 5:16 PM |
| 4 Top MedTech Stocks for Dividend Investors in 2017
finance.yahoo.com - September 8 at 5:16 PM |
| New Mexico sues opioid drug manufacturers, distributors
finance.yahoo.com - September 7 at 4:37 PM |
| Head-To-Head Review: Prestige Brand Holdings (PBH) and Cardinal Health (CAH)
www.americanbankingnews.com - September 4 at 2:12 PM |
| Recent Buy: Cardinal Health Inc.
seekingalpha.com - August 31 at 4:46 PM |
| Cardinal Health Becomes Oversold - Nasdaq
www.nasdaq.com - August 30 at 6:13 PM |
| Cardinal Health, Inc. (CAH) Given a $77.00 Price Target by Jefferies Group LLC Analysts
www.americanbankingnews.com - August 29 at 9:28 PM |
| Bert's Recent Buy - Cardinal Health
seekingalpha.com - August 24 at 4:58 PM |
| ETFs with exposure to Cardinal Health, Inc. : August 24, 2017
finance.yahoo.com - August 24 at 4:57 PM |
| Dividend Yield of Cardinal Health
finance.yahoo.com - August 23 at 5:04 PM |
 | Cardinal Health: Cramer's Top Takeaways - TheStreet.com
www.thestreet.com - August 22 at 10:34 PM |
| Cardinal Health, Inc. :CAH-US: Earnings Analysis: Q4, 2017 By the Numbers : August 21, 2017
finance.yahoo.com - August 22 at 10:34 PM |
| Cramer Remix: Why these US oil fields may be about to make a big market impact
finance.yahoo.com - August 22 at 10:34 PM |
| Cramer Remix: Why these US oil fields may be about to mak...
finance.yahoo.com - August 22 at 10:34 PM |
| Cardinal Health: Cramer's Top Takeaways
finance.yahoo.com - August 22 at 10:34 PM |
| Drug Distributors: Bear Vs. Bull Debate
finance.yahoo.com - August 21 at 4:48 PM |
| Cardinal Health, Inc. (CAH) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - August 17 at 12:08 AM |
| Cardinal Health, Inc. : CAH-US: Dividend Analysis : July 03rd, 2017 (record date) : By the numbers : August 16, 2017
finance.yahoo.com - August 16 at 5:24 PM |
| Cardinal Health, Inc. (CAH) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - August 15 at 8:50 PM |
| Head-To-Head Review: MWI Veterinary Supply (MWIV) & Cardinal Health (NYSE:CAH)
www.americanbankingnews.com - August 15 at 12:28 AM |
| Seth Klarman Bulks Up on Synchrony Despite Problems
finance.yahoo.com - August 14 at 5:20 PM |
| Cardinal Health, Inc. :CAH-US: Earnings Analysis: 2017 By the Numbers : August 14, 2017
finance.yahoo.com - August 14 at 5:20 PM |
| Pharmerica Corporation (PMC) and Cardinal Health (CAH) Financial Review
www.americanbankingnews.com - August 14 at 8:42 AM |
| Cardinal Health (CAH) versus Pharmerica Corporation (PMC) Head to Head Review
www.americanbankingnews.com - August 14 at 6:16 AM |
| IHS Markit Score downgrades Cardinal Health Inc to 26 out of 100, ranking positively in only one out of four IHS Markit categories.
finance.yahoo.com - August 11 at 5:22 PM |
| Pharmacy Distributor May Be Undervalued
finance.yahoo.com - August 10 at 6:01 PM |
| $33.43 Billion in Sales Expected for Cardinal Health, Inc. (CAH) This Quarter
www.americanbankingnews.com - August 10 at 5:16 PM |
| Cardinal Health, Inc. to Issue Quarterly Dividend of $0.46 (CAH)
www.americanbankingnews.com - August 9 at 4:46 PM |
| Cardinal Health, Inc. (CAH) Expected to Announce Earnings of $1.03 Per Share
www.americanbankingnews.com - August 8 at 7:32 AM |
| Why Cardinal Health is a Top 25 SAFE Dividend Stock (CAH)
www.nasdaq.com - August 7 at 5:21 PM |
| Cardinal Health, Inc. (NYSE:CAH) Downgraded by Zacks Investment Research
www.americanbankingnews.com - August 7 at 10:14 AM |
| Research Analysts Offer Predictions for Cardinal Health, Inc.'s Q1 2018 Earnings (CAH)
www.americanbankingnews.com - August 7 at 7:58 AM |
| Cardinal Health, Inc. (NYSE:CAH) Downgraded by BidaskClub to Sell
www.americanbankingnews.com - August 6 at 12:42 PM |
| Cardinal Health: Damaged Dividend Growth Story - Seeking Alpha - Seeking Alpha
seekingalpha.com - August 4 at 10:11 PM |
| Falling U.S. Generic Drug Prices Hurt Manufacturers, Wholesalers
finance.yahoo.com - August 4 at 5:09 PM |
| Cardinal Health, Inc. to Post Q2 2018 Earnings of $1.22 Per Share, Leerink Swann Forecasts (NYSE:CAH)
www.americanbankingnews.com - August 4 at 4:54 PM |
| Cardinal Health (CAH) & Pharmerica Corporation (PMC) Head-To-Head Contrast
www.americanbankingnews.com - August 4 at 4:39 PM |
| Q1 2018 Earnings Estimate for Cardinal Health, Inc. (CAH) Issued By William Blair
www.americanbankingnews.com - August 4 at 3:48 PM |
| Cardinal Health's (NYSE:CAH) "Neutral" Rating Reiterated at UBS AG
www.americanbankingnews.com - August 4 at 12:22 AM |
Cardinal Health (CAH) Chart for Monday, September, 25, 2017
